Received Feb 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
states he did not have the second dose of SHINGRIX administered in the recommended time; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (first dose of Shingrix on 23-JUN-2021 four years ago). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: states he did not have the second dose of SHINGRIX administered in the recommended time). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 17-FEB-2025 The patient was vaccinated with Shingrix first dose. The reporter stated he did not have the second dose of Shingrix administered in the recommended time specified in the package insert of two to six months for second dose. Till the time of reporting the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination.